Hirtle Callaghan & Co’s Eastman Chemical EMN Stock Holding History

Hirtle Callaghan & Co’s Portfolio EMN Stock Details EMN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-9,200	Closed	-$673K	–	89
2018 Q4	$673K	Hold	9,200	–	–	0.06%	47
2018 Q3	$881K	Hold	9,200	–	–	0.08%	39
2018 Q2	$920K	Hold	9,200	–	–	0.08%	36
2018 Q1	$971K	Hold	9,200	–	–	0.09%	34
2017 Q4	$852K	Hold	9,200	–	–	0.08%	41
2017 Q3	$833K	Buy	+9,200	New	+$783K	0.08%	40
2016 Q4	–	Sell	-9,200	Closed	-$623K	–	167
2016 Q3	$623K	Hold	9,200	–	–	0.13%	45
2016 Q2	$625K	Hold	9,200	–	–	0.12%	44
2016 Q1	$664K	Buy	+9,200	New	+$603K	0.12%	42
2015 Q1	–	Sell	-9,207	Closed	-$698K	–	123
2014 Q4	$698K	Hold	9,207	–	–	0.16%	85
2014 Q3	$745K	Hold	9,207	–	–	0.12%	84
2014 Q2	$804K	Buy	9,207 +7	+0.1%	+$608	0.11%	109
2014 Q1	$793K	Hold	9,200	–	–	0.13%	99
2013 Q4	$742K	Hold	9,200	–	–	0.1%	107
2013 Q3	$717K	Buy	+9,200	New	+$709K	0.12%	104

Other funds holding EMN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $178B AUM 37.23% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

Hirtle Callaghan & Co's EMN Position: Q1 2019 in Review

Hirtle Callaghan & Co sold out of Eastman Chemical (EMN) in Q1 2019, closing a stake of 9,200 shares — an estimated $673K sold.

Hirtle Callaghan & Co first reported a position in EMN in Q3 2013 and held it in 15 quarters. The position peaked at $971K in Q1 2018. 696 funds tracked by Wall St. Rank hold EMN as of Q1 2019.

Hirtle Callaghan & Co reported no remaining Eastman Chemical position as of Q1 2019 after selling out during the quarter.
Hirtle Callaghan & Co sold 9,200 Eastman Chemical shares in Q1 2019, an estimated $673K.
Hirtle Callaghan & Co first reported a position in Eastman Chemical in Q3 2013 and held it in 15 quarters.
Hirtle Callaghan & Co's Eastman Chemical position peaked at $971K in Q1 2018.
696 funds tracked by Wall St. Rank held Eastman Chemical as of Q1 2019.

Based on Hirtle Callaghan & Co's 13F filing for Q1 2019, filed 14 May 2019.